Fundraising FoxVascular Pharmaceuticals
Chapel Hill, US · Delaware corporation · 1 known investors
Find your way into Vascular Pharmaceuticals
Each arrow is one introduction. Sign up to fill in the first one.
Ask Beni Rovinski to introduce you to Richard Shea
You →Beni · together at Vascular Pharmaceuticals →Richard
Sign up to find every way you can get introduced to Vascular Pharmaceuticals
- Your email: who you already know at Vascular Pharmaceuticals, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Vascular Pharmaceuticals team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Vascular Pharmaceuticals develops VPI-2960B, a therapeutic candidate in clinical development for diabetic nephropathy treatment. The company focuses on advancing this potential breakthrough therapy through Phase 2 trials.
Founders & leadership
Board
Investors · 1
How we know: the company's own site · funding news · Not right? Tell us
Funding
SEC filings, press & company announcements$18.1M disclosed across 2 of 3 rounds · 2012–2015
- Undisclosed amountSeries AMar 2015Source ↗
▶$3MraisedJan 2016 · 6 investors · BiotechnologyRule 506(b)
- Benjamin RovinskiDirector
- Elizabeth StonerDirector
- David ClemmonsDirector
- Richard SheaExecutive Officer, Director
- Bonnie LaymanExecutive Officer
- Richard KentDirector
- Offering amount
- $3M
- Amount sold
- $3M
- First sale
- Dec 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$15.1MraisedFeb 2015 · 6 investors · BiotechnologyRule 506(b)
- David ClemmonsDirector
- Richard SheaExecutive Officer, Director
- Richard KentDirector
- Elizabeth StonerDirector
- Bonnie LaymanExecutive Officer
- Offering amount
- $25.1M
- Amount sold
- $15.1M
- First sale
- Sep 2012
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Vascular Pharmaceuticals went on to found or lead other companies.
Related companies · 2
Companies working in the same space as Vascular Pharmaceuticals.
In the news
Frequently asked questions
- What does Vascular Pharmaceuticals do?
- Vascular Pharmaceuticals develops VPI-2960B, a therapeutic candidate in clinical development for diabetic nephropathy treatment. The company focuses on advancing this potential breakthrough therapy through Phase 2 trials.
- Who founded Vascular Pharmaceuticals?
- Vascular Pharmaceuticals was founded by Laura Maile.
- Who are Vascular Pharmaceuticals's investors?
- Vascular Pharmaceuticals's investors include MPM BioImpact.
- How much funding has Vascular Pharmaceuticals raised?
- Vascular Pharmaceuticals has disclosed $18.1M raised across 2 of its 3 known rounds.
- Where is Vascular Pharmaceuticals headquartered?
- Vascular Pharmaceuticals is headquartered in Chapel Hill, US.